To better understand the technology behind what Medtronic leaders expect to become a multibillion-dollar business, Medical Design & Outsourcing spoke with Jason Weidman, Medtronic SVP and president of the coronary and renal denervation business, which is part of Medtronic’s cardiovascular portfolio.
Get the full story at our sister site, Medical Design & Outsourcing.